Over-expression and refolding of MAP kinase phosphatase 3

Area of Science:

• Biochemistry
• Molecular Biology
• Enzymology

Background:

• MAP kinase phosphatase 3 (MKP3) specifically dephosphorylates and inactivates ERK1 and ERK2, key regulators of cellular processes.
• Targeting the ERK pathway with MKP3 activators or inhibitors holds therapeutic potential.
• Efficient production of active MKP3 is crucial for drug discovery efforts.

Purpose of the Study:

• To establish a method for producing high yields of full-length, active human MKP3 from E. coli inclusion bodies.
• To develop a rapid, cost-effective assay for screening MKP3 refolding and activity.
• To validate the proper folding and functionality of the produced MKP3 protein.

Main Methods:

• Cloning and purification of full-length human MKP3 from E. coli inclusion bodies.
• Identification of optimal refolding conditions for MKP3.
• Development of a 96-well plate refolding assay using DMSO to simulate ERK-induced activity.
• Characterization of refolded MKP3 using steady-state kinetics and CD spectroscopy.

Main Results:

• Successful production of refolded, full-length human MKP3 from inclusion bodies.
• A 96-well plate assay enabled rapid, inexpensive assessment of MKP3 activity post-refolding.
• CD spectroscopy confirmed the secondary structure content of refolded MKP3, consistent with proper folding (36% helix, 14% sheet).

Conclusions:

• The developed refolding protocol and assay provide a robust platform for producing and screening active MKP3.
• This methodology supports the high-throughput screening of small molecules to identify MKP3 activators and inhibitors.
• The properly folded MKP3 protein is suitable for further functional studies and drug development targeting the ERK pathway.